SUPPLEMENTARY FUNDING OFFER FOR THE MRC UNIT, THE GAMBIA AT LSHTM (resource to support a clinical trial of Hydroxychloroquine and Azithromycin, studies on the transmission and antibody dynamics to SARS-CoV-2 infection, and to further support
- Funded by UK Research and Innovation (UKRI)
- Total publications:6 publications
Grant number: MC_PC_19084
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$5,500,000Funder
UK Research and Innovation (UKRI)Principal Investigator
Prof. Umberto D'AlessandroResearch Location
GambiaLead Research Institution
London School of Hygiene & Tropical MedicineResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Clinical trial (unspecified trial phase)
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
This £4.4m award provides resource to support a clinical trial of Hydroxychloroquine and Azithromycin, studies on the transmission and antibody dynamics to SARS-CoV-2 infection, and to further support surveillance activities funded by BMGF.
Publicationslinked via Europe PMC
Last Updated:2 hours ago
View all publications at Europe PMC